141 related articles for article (PubMed ID: 3011236)
1. Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prognosis, and other biochemical markers.
Gronowitz JS; Steinholtz L; Källander CF; Hagberg H; Bergh J
Cancer; 1986 Jul; 58(1):111-8. PubMed ID: 3011236
[TBL] [Abstract][Full Text] [Related]
2. Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis.
Gronowitz JS; Bergström R; Nôu E; Påhlman S; Brodin O; Nilsson S; Källander CF
Cancer; 1990 Aug; 66(4):722-32. PubMed ID: 2167141
[TBL] [Abstract][Full Text] [Related]
3. Prognostic influence of TNM staging and LDH levels in small cell carcinoma of the lung (SCCL).
Byhardt RW; Hartz A; Libnoch JA; Hansen R; Cox JD
Int J Radiat Oncol Biol Phys; 1986 May; 12(5):771-7. PubMed ID: 3011712
[TBL] [Abstract][Full Text] [Related]
4. Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer.
Jørgensen LG; Hansen HH; Cooper EH
Eur J Cancer Clin Oncol; 1989 Jan; 25(1):123-8. PubMed ID: 2537729
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment serum lactate dehydrogenase as additional staging parameter in patients with small-cell lung carcinoma.
Stokkel MP; van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
J Cancer Res Clin Oncol; 1998; 124(3-4):215-9. PubMed ID: 9619749
[TBL] [Abstract][Full Text] [Related]
6. Is there any clinical relevance of serial determinations of serum carcinoembryonic antigen in small cell lung cancer patients?
Krischke W; Niederle N; Schütte J; Pfeiffer R; Hirche H
Cancer; 1988 Oct; 62(7):1348-54. PubMed ID: 2843279
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of three biochemical markers for serially monitoring the therapy of small-cell lung cancer.
Ganz PA; Ma PY; Wang HJ; Elashoff RM
J Clin Oncol; 1987 Mar; 5(3):472-9. PubMed ID: 3029340
[TBL] [Abstract][Full Text] [Related]
8. Activity of serum thymidine kinase in non-Hodgkin lymphoma: relationship to other prognostic factors.
Hallek M; Emmerich B; Strohmeyer S; Busch R; Reichle A; Senekowitsch R
Klin Wochenschr; 1988 Aug; 66(16):718-23. PubMed ID: 3172680
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
J Clin Oncol; 1991 Jun; 9(6):954-61. PubMed ID: 1851821
[TBL] [Abstract][Full Text] [Related]
10. Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer.
Johnson PW; Joel SP; Love S; Butcher M; Pandian MR; Squires L; Wrigley PF; Slevin ML
Br J Cancer; 1993 Apr; 67(4):760-6. PubMed ID: 8385978
[TBL] [Abstract][Full Text] [Related]
11. Serum biomarkers of non-neuron-endocrine origin in small-cell lung cancer: a 16-year study on carcinoembryonic antigen, tissue polypeptide antigen and lactate dehydrogenase.
Buccheri G; Ferrigno D;
Lung Cancer; 2000 Oct; 30(1):37-49. PubMed ID: 11008008
[TBL] [Abstract][Full Text] [Related]
12. [Clinical application of thymidine kinase activity in patients with acute non-lymphocytic leukemia].
Sampi K; Takagi T; Sakai C; Kuraishi Y; Ishige K
Gan To Kagaku Ryoho; 1991 Jan; 18(1):69-73. PubMed ID: 1987902
[TBL] [Abstract][Full Text] [Related]
13. Correlation between serum tumor marker levels and tumor proliferation in small cell lung cancer.
Lehtinen M; Wigren T; Lehtinen T; Kallioniemi OP; Aine R; Aaran RK; Ojala A
Tumour Biol; 1988; 9(6):287-92. PubMed ID: 2849799
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), enolase (NSE) and thymidine-kinase (TK) in the monitoring and prognosis of primary carcinoma of the lung].
De Angelis G; De Marinis F; Bigioni D; Migliorino MR; Alma MG; Pigorini F
J Nucl Med Allied Sci; 1990; 34(4 Suppl):135-40. PubMed ID: 1965445
[No Abstract] [Full Text] [Related]
15. Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.
Jørgensen LG; Osterlind K; Genollá J; Gomm SA; Hernández JR; Johnson PW; Løber J; Splinter TA; Szturmowicz M
Br J Cancer; 1996 Aug; 74(3):463-7. PubMed ID: 8695366
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of serum lactic dehydrogenase in non-Hodgkin's lymphoma.
Hagberg H; Siegbahn A
Scand J Haematol; 1983 Jul; 31(1):49-56. PubMed ID: 6867608
[TBL] [Abstract][Full Text] [Related]
17. [The importance of measuring plasma carcinoembryonic antigen in small-cell anaplastic carcinoma].
Michetti G; Bamberga M; Pugliese C; Ori Belometti M; Arnone P; Minio A; Ciaravino G; Villa R; Alesina R; Cottini M
Minerva Med; 1994 May; 85(5):231-6. PubMed ID: 8028751
[TBL] [Abstract][Full Text] [Related]
18. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of thymidine kinase for the diagnosis, therapy monitoring and prognosis of non-operable lung cancer.
Holdenrieder S; Von Pawel J; Duell T; Feldmann K; Raith H; Schollen A; Nagel D; Stieber P
Anticancer Res; 2010 May; 30(5):1855-62. PubMed ID: 20592392
[TBL] [Abstract][Full Text] [Related]
20. [The value of carcinoembryonic antigens in patients with advanced lung cancer: in relation to chemotherapy].
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Takahashi K; Sasaki Y; Ohkura H
Gan To Kagaku Ryoho; 1984 May; 11(5):1056-63. PubMed ID: 6202246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
